Rock Peter, Slavova Svetla, Westgate Philip M, Nakamura Aisaku, Walsh Sharon L
Substance Use Priority Research Area, Office of the Vice President for Research, University of Kentucky, Lexington, KY, USA,.
Department of Biostatistics, College of Public Health, University of Kentucky, Lexington, KY, USA,; Kentucky Injury Prevention and Research Center, University of Kentucky, Lexington, KY, USA,.
Drug Alcohol Depend. 2024 Feb 1;255:111062. doi: 10.1016/j.drugalcdep.2023.111062. Epub 2023 Dec 14.
Fatal overdoses involving fentanyl/fentanyl analogs (F/FA) have increased in the US, raising questions about naloxone doses for F/FA overdose reversal. Emergency medical services (EMS) data provide an opportunity to examine naloxone administration changes as fentanyl increases in the illicit opioid supply.
Administered naloxone intranasal-equivalent total dose (INTD) in milligrams (mg) was calculated for Kentucky EMS suspected opioid overdose (SOO) encounters (n=33,846), 2018-2021, and patterns of administration were examined. County-level F/FA availability was measured as 1) proportion of fatal drug overdoses involving F/FA, and 2) F/FA police seizures. Linear mixed models estimated changes in INTD in relation to local F/FA availability accounting for patient characteristics.
From 2018-2021, SOOs increased by 44% (6853 to 9888) with an average INTD increase from 4.5mg to 4.7mg, with more than 99% of encounters resulting in successful reversal each year. For SOO encounters examined by outcome at the scene (i.e., non-fatal fatal vs fatal), average INTD for non-fatal were 4.6mg compared to 5.9mg for fatal overdoses. Mixed modeling found no significant relationship between INTD and the two measures for local F/FA availability.
As F/FA-involved overdose risk increased, we observed a modest increase in INTD administered in SOO EMS encounters - just slightly higher than the 4mg standard dose. The lack of significant relationship between F/FA and naloxone dose suggests that naloxone utilization in SOO with EMS involvement remains effective for overdose reversal, and that EMS naloxone dosing patterns have not changed substantially.
在美国,涉及芬太尼/芬太尼类似物(F/FA)的致命过量用药情况有所增加,这引发了关于用于逆转F/FA过量用药的纳洛酮剂量的问题。紧急医疗服务(EMS)数据为研究随着非法阿片类药物供应中芬太尼含量增加,纳洛酮使用情况的变化提供了契机。
计算了2018 - 2021年肯塔基州紧急医疗服务机构疑似阿片类药物过量用药(SOO)事件(n = 33846)中经鼻给予的纳洛酮等效总剂量(INTD,以毫克为单位),并研究了用药模式。县级F/FA可获得性通过以下两项指标衡量:1)涉及F/FA的致命药物过量用药比例;2)F/FA警方查获量。线性混合模型估计了与当地F/FA可获得性相关的INTD变化,并考虑了患者特征。
从2018年到2021年,SOO事件增加了44%(从6853起增至9888起),平均INTD从4.5毫克增加到4.7毫克,每年超过99%的事件成功实现逆转。对于在现场按结果(即非致命与致命)分类的SOO事件,非致命事件的平均INTD为4.6毫克,而致命过量用药事件为5.9毫克。混合模型分析发现,INTD与当地F/FA可获得性的两项衡量指标之间无显著关系。
随着涉及F/FA的过量用药风险增加,我们观察到在SOO紧急医疗服务事件中给予的INTD有适度增加——仅略高于4毫克的标准剂量。F/FA与纳洛酮剂量之间缺乏显著关系表明,在紧急医疗服务介入的SOO事件中使用纳洛酮对逆转过量用药仍然有效,并且紧急医疗服务的纳洛酮给药模式没有实质性变化。